Skip to content

Exercise Pulmonary Transit Time

Echocardiographic Assessment of Pulmonary Transit Time Following Exercise

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04336995
Enrollment
14
Registered
2020-04-07
Start date
2020-08-27
Completion date
2024-03-01
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Diastolic

Brief summary

The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.

Detailed description

The ability to measure the amount of blood in the lungs using heart-ultrasound (echocardiography) can be useful to estimate how much fluid is in a patient's circulation, which can influence diagnosis and treatment of certain types of heart failure. In some patients, the amount of fluid is normal at rest, but can increase with activity and thus a diagnosis of heart failure can only be made after exercising. Currently, the amount of fluid is measured invasively. We have shown that echocardiography can measure the amount of fluid in the lung circulation at rest without the need for an invasive procedure. We now seek to find out if we can make a similar measurement after exercise. If successful, the need for catheter procedures may be reduced in certain types of heart failure.

Interventions

giving echocardiographic contrast and taking echocardiographic images before and after exercise

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

small pilot study to test technical feasibility

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age ≥ 18 years old 2. Able to give informed consent

Exclusion criteria

1. Known allergic reaction to Definity or Optison ultrasound contrast 2. Pregnancy/Nursing - as assessed/disclosed by the participant

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary Transit Time3-10 secondsinterval required for the pulmonary blood volume to traverse the pulmonary circulation

Countries

United States

Participant flow

Participants by arm

ArmCount
Exercise
Everyone is in this arm contrast echocardiography: giving echocardiographic contrast and taking echocardiographic images before and after exercise
14
Total14

Baseline characteristics

CharacteristicExercise
Age, Continuous46 years
STANDARD_DEVIATION 8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
13 Participants
Region of Enrollment
United States
14 participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 14
other
Total, other adverse events
0 / 14
serious
Total, serious adverse events
0 / 14

Outcome results

Primary

Pulmonary Transit Time

interval required for the pulmonary blood volume to traverse the pulmonary circulation

Time frame: 3-10 seconds

ArmMeasureValue (MEAN)Dispersion
ExercisePulmonary Transit Time2.5 secondsStandard Deviation 0.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026